Clinical Trial

Personalized Two-stage Regional Citrate Anticoagulation for CRRT in Patients With Citrate Metabolism Impairment

Name: Personalized Two-stage Regional Citrate Anticoagulation for CRRT in Patients With Citrate Metabolism Impairment — clinical trial record (NCT07579663)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRECISE

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to compare the efficacy and safety of an individualized two-stage calcium supplementation method versus a conventional commercial RCA-CRRT module in RCA-CRRT for patients with citrate metabolism disorders.

Trial Details

NCT Number	NCT07579663
Lead Sponsor	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Conditions	AKI - Acute Kidney Injury, CKD 5D, Hemodialysis, Hepatic Failure
Enrollment	142 participants
Start Date	2026-05-05
Primary Completion	2028-02-14 (estimated)
Study Completion	2028-08-14 (estimated)
Updated on ClinicalTrials.gov	2026-05-12